Mevalonic aciduria (Q97697)

From determinar.ia.br - Determine suas informações
Revision as of 13:49, 16 August 2026 by Determinaradmin (talk | contribs) (‎Changed label, description and/or aliases in pt-br, en)
Mevalonic aciduria (MVA) and hyperimmunoglobulinaemia D syndrome (HIDS) represent the two ends of a clinical spectrum of disease caused by deficiency of mevalonate kinase (MVK), the first committed enzyme of cholesterol biosynthesis. MVA is characterised by psychomotor retardation, failure to thrive, progressive cerebellar ataxia, dysmorphic features, progressive visual impairment and recurrent febrile crises with hepatosplenomegaly, lymphadenopathy, abdominal symptoms, arthralgia and skin rashes. In HIDS, only febrile attacks are present, but a subgroup of patients may also develop neurological abnormalities of varying degree such as intellectual deficit, ataxia, ocular symptoms and epilepsy.
Language Label Description Also known as
default for all languages
ID_572875152
    English
    Mevalonic aciduria
    Mevalonic aciduria (MVA) and hyperimmunoglobulinaemia D syndrome (HIDS) represent the two ends of a clinical spectrum of disease caused by deficiency of mevalonate kinase (MVK), the first committed enzyme of cholesterol biosynthesis. MVA is characterised by psychomotor retardation, failure to thrive, progressive cerebellar ataxia, dysmorphic features, progressive visual impairment and recurrent febrile crises with hepatosplenomegaly, lymphadenopathy, abdominal symptoms, arthralgia and skin rashes. In HIDS, only febrile attacks are present, but a subgroup of patients may also develop neurological abnormalities of varying degree such as intellectual deficit, ataxia, ocular symptoms and epilepsy.

      Statements